在日本规划和实施总体协议试验:日本指导方针的关键考虑
Akihiro Hirakawa1, Takashi Asakawa2, Kota Tokushige3
1Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Clinical pharmacology and therapeutics
|November 22, 2024
概括
日本 日本 日本 日本 日本.
科学领域:
- 临床试验方法论 临床试验方法论
- 监管科学是一种监管科学.
- 药物开发 药物开发
背景情况:
- 主协议试验 (篮子,雨,平台) 提高了评估多种药物或疾病的效率.
- 全球监管机构,如美国FDA和欧洲机构已经为这些复杂的试验制定了指导方针.
- 日本独特的医疗保健和监管环境需要对总体协议试验的具体指导.
研究的目的:
- 详细阐述日本新发布的关于总体协议试验的指南.
- 为指南的结构,内容和实施考虑提供全面的概述.
- 突出在日本的特定背景下进行总体协议试验的适应性.
主要方法:
- 合作开发涉及生物统计学家,医生,临床试验人员,监管机构和行业代表.
- 对日本新发布的指导方针进行全面的审查和分析.
- 专注于实际的规划和实施方面.
主要成果:
- 详细解释了日本总体协议试验指南的结构和内容.
- 确定对日本景观所需的关键考虑和具体适应.
- 重点是指导方针创建背后的合作努力.
结论:
- 日本的新指导方针为高效的总体协议试验提供了一个框架.
- 这些指导方针针对日本监管体系中独特的挑战和机遇.
- 该研究有助于优化全球临床试验框架和药物开发.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
3.7K
相关概念视频
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Administration and Therapy Phases: Overview
1.9K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.9K
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
